bupropion and carbostyril

bupropion has been researched along with carbostyril in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dobkin, RD; Marin, H; Menza, MA1
Sokolski, KN1
Elkashef, A; Hanson, G; Tiihonen, J; Vocci, F; White, J; Wickes, W1
Crayton, J; Nasr, S; Popli, A; Wendt, B1
Baker, RA; Berman, RM; Cain, ZJ; Clayton, AH; Forbes, RA; Marcus, R; Marler, SV; Sheehan, JJ; Thase, ME1
Baker, RA; Fava, M; Matsushima, Y; Okame, T; Perry, P; Weiller, E1
Aladeen, T; Capote, H; Lee, Y; McIntyre, RS; Rainka, M; Rong, C; Westphal, E1

Reviews

1 review(s) available for bupropion and carbostyril

ArticleYear
Pharmacotherapy of methamphetamine addiction: an update.
    Substance abuse, 2008, Volume: 29, Issue:3

    Topics: Antipsychotic Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Dextroamphetamine; Drug Therapy; Humans; Lobeline; Methamphetamine; Methylphenidate; Narcotic Antagonists; Nicotinic Agonists; Piperazines; Prevalence; Quinolones; Recurrence; Substance-Related Disorders

2008

Trials

3 trial(s) available for bupropion and carbostyril

ArticleYear
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Bupropion; Dizziness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Pilot Projects; Piperazines; Quality of Life; Quinolones; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2007
Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    BMC research notes, 2014, Jul-18, Volume: 7

    Topics: Adult; Antidepressive Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Norepinephrine; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors; Serotonin; Sexual Behavior; Treatment Outcome

2014
Switching from Inadequate Adjunctive or Combination Treatment Options to Brexpiprazole Adjunctive to Antidepressant: An Open-Label Study on the Effects on Depressive Symptoms and Cognitive and Physical Functioning.
    The international journal of neuropsychopharmacology, 2017, 01-01, Volume: 20, Issue:1

    Topics: Antidepressive Agents; Aripiprazole; Bupropion; Central Nervous System Stimulants; Cognition; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Drug Therapy, Combination; Female; Humans; Impulsive Behavior; Male; Middle Aged; Psychiatric Status Rating Scales; Quetiapine Fumarate; Quinolones; Sleep; Thiophenes; Treatment Outcome

2017

Other Studies

3 other study(ies) available for bupropion and carbostyril

ArticleYear
Adjunctive aripiprazole for bupropion-resistant major depression.
    The Annals of pharmacotherapy, 2008, Volume: 42, Issue:7

    Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Bupropion; Depressive Disorder; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones

2008
Comparing outcomes of adjunctive treatment in depression: aripiprazole versus bupropion.
    Journal of affective disorders, 2014, Volume: 162

    Topics: Adult; Antidepressive Agents; Aripiprazole; Bupropion; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Piperazines; Quinolones; Retrospective Studies

2014
The use of brexpiprazole amongst individuals with insufficient outcomes with aripiprazole or bupropion: A case series.
    Perspectives in psychiatric care, 2018, Volume: 54, Issue:4

    Topics: Adult; Antipsychotic Agents; Aripiprazole; Bupropion; Depressive Disorder, Major; Female; Humans; Male; Middle Aged; New York; Psychiatric Status Rating Scales; Quinolones; Retrospective Studies; Thiophenes; Treatment Outcome; Young Adult

2018